Search - tctmd.com

Displaying 921 - 936 of 936

Sort: Relevancy | Date

News Daily News

Aspirin’s GI Bleeding Risk Increased by Concomitant Use of Gastrotoxic Drugs

Caitlin E. Cox

March 10, 2011

News Daily News

Women Less Likely to Receive Evidence-Based Therapies Than Men

Jason Kahn

March 09, 2011

News Daily News

In-Hospital Mortality Equal for Men, Women After PCI for STEMI

Caitlin E. Cox

February 08, 2011

News Daily News

Improvements in Care for PCI Patients with PAD Fail to Budge Mortality, MI Rates

February 07, 2011

News Daily News

High-Dose Maintenance Clopidogrel Lowers Platelet Reactivity, Other Risk Factors

February 06, 2011

News Daily News

Another Study Finds No Interaction Between PPIs and Clopidogrel

L.A. McKeown

January 27, 2011

News Daily News

More Than 1 in 10 Patients Discontinue Antiplatelet Therapy Early

L.A. McKeown

January 24, 2011

News Daily News

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

January 09, 2011

News Daily News

Year in Review: Highlights of 2010 Include Data on Valvular Therapy, CTA Progress

Caitlin E. Cox

January 02, 2011

News

SYNTAX Published: CABG Remains Standard for Severe CAD

Caitlin E. Cox

February 18, 2009

News Daily News

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

November 11, 2008

Video

» Topical Discussion

Quick Takes: Ariela Orkaby on Statin Use in HFpEF Patients

May 13, 2024

Video

» Interview

Beyond the Data: STOP-CA: A Role for Statins against Anthracyclines?

March 5, 2023

CME

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

Video

» On Record

On Record: Low-Dose Statins and Antihypertensives for Intermediate Risk CVD: HOPE-3

May 11, 2018

CME

Advertisement

Aspirin’s GI Bleeding Risk Increased by Concomitant Use of Gastrotoxic Drugs

Women Less Likely to Receive Evidence-Based Therapies Than Men

In-Hospital Mortality Equal for Men, Women After PCI for STEMI

Improvements in Care for PCI Patients with PAD Fail to Budge Mortality, MI Rates

High-Dose Maintenance Clopidogrel Lowers Platelet Reactivity, Other Risk Factors

Another Study Finds No Interaction Between PPIs and Clopidogrel

More Than 1 in 10 Patients Discontinue Antiplatelet Therapy Early

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

Year in Review: Highlights of 2010 Include Data on Valvular Therapy, CTA Progress

SYNTAX Published: CABG Remains Standard for Severe CAD

JUPITER: Rosuvastatin Cuts Heart Risk, Even In LDL-Normal Patients

Quick Takes: Ariela Orkaby on Statin Use in HFpEF Patients

Beyond the Data: STOP-CA: A Role for Statins against Anthracyclines?

Role of Interventional Cardiologists in Secondary Prevention of Acute Coronary Syndromes: Redefining Clinical Practice

On Record: Low-Dose Statins and Antihypertensives for Intermediate Risk CVD: HOPE-3

Severe/Resistant Hypercholesterolemia: New Agents Redefining Clinical Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content